XBiotech Inc (XBIT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.35
• Market Cap: $71.95M
• EPS: $-0.95
• 52-Week High: $3.62
• 52-Week Low: $2.09

About XBiotech Inc

XBiotech Inc. is a transformative biopharmaceutical company based in Austin, Texas, specializing in the development of True Human monoclonal antibodies aimed at treating a range of diseases. Leveraging advanced technology to utilize human immune cells, the company seeks to create innovative and safer therapeutic options. With a diverse and promising pipeline, XBiotech is strategically positioned as a frontrunner in the biotherapeutics arena, committed to enhancing patient care and addressing ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for XBiotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XBIT pay dividends?

XBiotech Inc (XBIT) does not currently pay a regular dividend.

What is XBIT's market cap?

XBiotech Inc (XBIT) has a market capitalization of $71.95M with a current stock price of $2.35.